JW Pharmaceutical Corporation (KRX:001065)
29,650
-200 (-0.67%)
Dec 19, 2025, 3:30 PM KST
JW Pharmaceutical Market Cap
JW Pharmaceutical has a market cap or net worth of 644.77 billion as of December 19, 2025. Its market cap has increased by 16.26% in one year.
Market Cap
644.77B
Enterprise Value
630.93B
Revenue
764.21B
Ranking
n/a
PE Ratio
11.12
Stock Price
29,650.00
Market Cap Chart
Since April 29, 2003, JW Pharmaceutical's market cap has increased from 84.02B to 644.77B, an increase of 667.38%. That is a compound annual growth rate of 9.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 644.77B | 14.79% |
| Dec 30, 2024 | 561.70B | -32.21% |
| Dec 28, 2023 | 828.52B | 97.41% |
| Dec 29, 2022 | 419.69B | -17.00% |
| Dec 30, 2021 | 505.68B | -32.85% |
| Dec 30, 2020 | 753.06B | 22.16% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 81.01T |
| Celltrion | 40.48T |
| ALTEOGEN | 22.52T |
| SK Biopharmaceuticals | 10.26T |
| ABL Bio | 10.04T |
| Yuhan | 8.53T |
| LigaChem Biosciences | 6.14T |
| HLB Co., Ltd. | 6.11T |